In partnership with
Anna's Daybreak News
Just facts, you think for yourself
Wednesday, 5:15 AM
August 5, 2026
Good morning news friend! Discover today’s defining stories and the future they set in motion. 📰🌟
Today’s Daybreak: Michigan Democrats face a Senate primary that could redraw the party’s fault line. The Iran war may be draining America’s missile stockpiles faster than officials admit. A scaffold treatment helps mouse brains rebuild after stroke. AI safety rules get a carveout. And in markets and health: Chipotle’s jalapeño problem widens, while SpaceX revenue surges but AI spending bites.
Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.
This free version is ad-supported.
Short on cash? Get up to $750, no credit check.
Access up to $750* from your upcoming paycheck within minutes for a small fee, or wait 3 days and get it for free. No credit check. No late fees.
*Not all users will qualify. Advances range from $25–$750; average advance is $170. Express transfer fees may apply.
Don’t want to see ads anymore? Click here for an ad-free experience
At 3:00 a.m., your throat closes.
No dramatic gasping.
No chainsaw snoring.
Just silence.
Nine seconds later, your brain notices the oxygen dropping and hits the panic button.
Adrenaline floods your bloodstream. Your airway snaps open. And you keep sleeping like nothing happened.
You won’t remember it in the morning.
The only clues?
A blood pressure reading your doctor can’t explain. And the kind of exhaustion you’ve slowly accepted as “getting older.”
But here’s the crazy part:
You could take a sleep study and still be told everything looks “normal.”
That’s how millions of oxygen-starved nights slip through the cracks.
We dug into why the standard tests miss them—and what the real treatment options look like in 2026.
Here’s what may actually be happening while you sleep:
The Snoring Myth & The Post-Menopausal Risk Multiplier
Think sleep apnea only affects heavy men who snore like freight trains? Think again. We look at why 80% of cases go undiagnosed, why post-menopausal women face a 2.5x higher risk, and how skinny, fit adults get tricked into a decade of delay. [Read Section 1: The Clinical Blindspot]
The 3:00 AM Adrenaline Loop
What actually happens to your body when your brain panics every ninety seconds? We break down how micro-suffocations trigger silent spikes in blood pressure, reset your baseline autonomic tone during the day, and shred your deep REM sleep. [Read Section 2: Nocturnal Hypoxia and the Adrenaline Loop]
The Home Test Trap
Taking a home sleep study seems convenient, but standard home tests systematically undercount your events by up to 15%. We explain how to prep for a test so you don't waste weeks on a false reading, plus how to interpret the numbers that actually matter. [Read Section 3: Screening and the HSAT]
The 3% vs. 4% Scoring Trap: Why Your Test Said "Normal"
This is the biggest administrative glitch in modern sleep medicine. The American Academy of Sleep Medicine uses a 3% oxygen drop to count an event. Medicare and many insurers still use a 4% rule from 2001. That tiny 1% gap leaves millions—especially women—with a "normal" grade while experiencing severe hypoxia. We show you how to audit your own report and request a re-score. [Read Section 4: The 3% vs. 4% Scoring Trap]
The CPAP Reality Check
CPAP works, but half of the people who get one stop using it within months. We break down what major clinical trials actually showed about heart health, and why "mean disease alleviation" means alternative treatments might be just as effective in the real world. [Read Section 5: The Adherence Reality]
The Silent Mouthguard Option
If you hate the mask, you aren't out of options. Custom mandibular advancement devices pull your jaw forward and keep the airway open without hoses or noise. We look at who qualifies, the dental side effects nobody warns you about, and how to get one fitted right. [Read Section 6: Oral Appliances]
The 2026 Treatment Upgrade: Beyond the Mask
The treatment menu just changed dramatically. From newly FDA-approved GLP-1 options to a targeted neuromuscular pill currently sitting at the FDA, plus leadless nerve stimulation implants, the choices in 2026 look nothing like they did three years ago. [Read Section 7: The Menu Just Got Longer]
If you wake up tired, struggle with stubborn blood pressure, or were told your sleep test was fine, you need to see this.
Michigan Split
Michigan Democrats are choosing between two Senate candidates with contrasting bases: Abdul El-Sayed, a former public health official backed by Bernie Sanders and AOC, and Haley Stevens, a four-term House member backed by Whitmer, Peters, Stabenow and Pelosi.
Michigan’s Democratic Senate primary was tight, with Abdul El-Sayed leading Rep. Haley Stevens 49% to 47% and Mallory McMorrow at 4% with most votes counted.
El-Sayed leads recent polls and would be the first Muslim senator if elected. Stevens has drawn about $30 million from AIPAC.
The race hinges on party direction, Israel and control of the 2026 Senate map. The winner faces former Rep. Mike Rogers on Nov. 3. Polls show mixed general-election matchups.
The Justice Department also sent election monitors to several Michigan cities for the primary.
Do you think the Democratic party will lean more towards the left or center in the November elections?
This free version is ad-supported.
Apple’s Starlink Update Sparks Huge Earning Opportunity
Apple just secretly added Starlink satellite support to iPhones through iOS 18.3.
One of the biggest potential winners? Mode Mobile.
Mode’s EarnPhone already reaches 490M+ users that have earned over $1B, and that’s before global satellite coverage. With SpaceX eliminating "dead zones," Mode's earning technology can now reach billions more in unbanked and rural populations worldwide.
Their global expansion is perfectly timed, and investors like you still have a chance to invest in their pre-IPO offering at $0.52/share.
With their recent 32,481% revenue growth and newly reserved Nasdaq ticker, Mode is one step closer to a potential IPO.
Please read the offering circular and related risks at invest.modemobile.com. This is a paid advertisement for Mode Mobile’s Regulation A+ Offering.
Mode Mobile recently received their ticker reservation with Nasdaq ($MODE), indicating an intent to IPO in the next 24 months. An intent to IPO is no guarantee that an actual IPO will occur.
The Deloitte rankings are based on submitted applications and public company database research, with winners selected based on their fiscal-year revenue growth percentage over a three-year period.
Don’t want to see ads anymore? Click here for an ad-free experience
Missile Drain
The U.S. has burned through nearly all of its long-range precision missile stockpiles in the war with Iran, including almost all ATACMS and PrSM missiles and more than half of its Tomahawks.
Defensive inventories have also shrunk: Patriot interceptors fell from about 2,330 before the war to 759-827 by late July, while THAAD interceptors dropped from 452 to 234-278.
A CSIS report says restoring both to prewar levels could take until mid-2029. Officials say the U.S. can’t keep up the early-war pace, despite Trump and Hegseth downplaying shortages.
Trump said the U.S. has “far more munitions than anyone in the world” and “far more than we need.” Hegseth called the stockpile concerns “a manufactured story.”
Do you trust official statements that U.S. missile shortages are overstated?
Stroke Repair Hub
Researchers injected a microporous scaffold called MAPS into mouse stroke cavities 5 days after injury, then added astrocyte-derived extracellular vesicles.
The combination attracted immune cells, boosted blood vessel and nerve-fiber growth, and improved movement; by 8 weeks, treated mice performed like healthy controls in a grid-walking test.
EVs from astrocytes exposed to IL-4 and C1q worked best. Neutrophils were essential: removing neutrophil-rich immune cells sharply reduced vessel growth and scaffold remodeling.
EVs alone did not match the full effect, suggesting the scaffold and vesicles both drive repair.
Sources: SciTechDaily
Do you think injecting a scaffold into the brain is an acceptable approach to stroke repair?
This free version is ad-supported.
Master Claude AI (Free Guide)
The professionals pulling ahead aren't working more. They're using Claude.
Our free guide will show you how to:
Configure Claude to be the perfect assistant
Master AI-powered content creation
Transform complex data into actionable strategies
Harness Claude’s full potential
Transform your workflow with AI and stay ahead of the curve with this comprehensive guide to using Claude at work.
Don’t want to see ads anymore? Click here for an ad-free experience
AI Gatekeeping
The Trump administration will exempt U.S. open-weight AI models from pre-release government testing, while keeping possible voluntary review for closed, proprietary models that score highly on cybersecurity and hacking benchmarks.
The unpublished framework is likely to affect OpenAI, Anthropic and Google, and may later extend to more powerful open-weight systems.
The policy follows Trump’s June executive order on AI security risk and aims to balance safety with innovation.
Critics say voluntary review may miss risks, especially from open-source models and Chinese firms. New testing incidents involving OpenAI and Anthropic have increased pressure for tighter AI security oversight.
Sources: WallStreetJournal, Bloomberg, NYTimes
Do you think voluntary AI safety testing is sufficient for frontier models?
Jalapeño Probe
Chipotle removed jalapeños from several Minnesota stores after officials linked them to a salmonella outbreak. Minnesota has reported 110 illnesses; 75 of 84 interviewed patients said they ate at Chipotle between June 14 and July 14.
Chipotle said it swapped in peppers from other growers after learning of a possible supply-chain problem.
The Minnesota health department said it is not concerned about Chipotle now, but the outbreak source remains unclear.
The FDA began investigating July 22 and linked 212 cases in a multistate salmonella javiana outbreak. Chipotle shares fell 9.7% Tuesday, their worst drop since Oct. 30.
Sources: Bloomberg
Would you still eat at Chipotle after hearing about this salmonella outbreak?
SpaceX Results
SpaceX posted second-quarter revenue of $7.8 billion, up 92% year over year and above estimates, while its loss narrowed to 9 cents a share.
Capex surged to $18.4 billion, with $15.8 billion directed to AI. Starlink reached 12 million subscribers and $4.3 billion in revenue, keeping it the only profitable unit.
The AI business generated $2.6 billion but lost $1.26 billion. Musk said SpaceX wants space data centers in 2027 and $1 trillion in revenue by 2030. The stock fell as much as 8.8% after the report.
Sources: AP News, Bloomberg, WallStreetJournal
Do you think SpaceX’s spending surge is a sign of smart long-term growth?
“With a truly mature man, short sentences carry the weight of grand orations, and simple acts become decisive deeds. Maturity finishes a man off, for he is only as complete as the gravity he possesses.”
-Roman Proverb
Information is free. Intelligence is scarce.
You are one of 550,000 readers receiving this briefing. That is a crowd.
To join the 1,800 investors who receive our redacted contract briefings and wealth defense protocols, you need to step behind the velvet rope.
Join the Inner Circle.
Baked with love,
Anna Eisenberg ❤️